Arrowstreet Capital
CDNA icon

Arrowstreet Capital’s CareDx CDNA Stock Holding History

Arrowstreet Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.6M Buy
+372,111
New +$8.1M ﹤0.01% 1059
2025
Q2 		– Sell
-38,580
Closed -$685K – 1938
2025
Q1 		$685K Buy
38,580
+4,418
+13% +$95.2K ﹤0.01% 1567
2024
Q4 		$731K Buy
+34,162
New +$831K ﹤0.01% 1521
2024
Q2 		– Sell
-216,891
Closed -$2.3M – 1546
2024
Q1 		$2.3M Sell
216,891
-129,006
-37% -$1.29M ﹤0.01% 1102
2023
Q4 		$4.15M Buy
+345,897
New +$2.83M ﹤0.01% 803
2021
Q4 		– Sell
-11,900
Closed -$754K – 1465
2021
Q3 		$754K Sell
11,900
-12,600
-51% -$960K ﹤0.01% 1352
2021
Q2 		$2.24M Buy
24,500
+16,600
+210% +$1.32M ﹤0.01% 1313
2021
Q1 		$538K Buy
+7,900
New +$613K ﹤0.01% 1976
2020
Q4 		– Sell
-20,724
Closed -$786K – 2304
2020
Q3 		$786K Buy
+20,724
New +$700K ﹤0.01% 1884

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arrowstreet Capital's CDNA Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in CareDx (CDNA) in Q2 2026: 372,111 shares worth $10.6M. The stake represents ﹤0.01% of the portfolio and ranks #1059 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in CDNA as recently as Q1 2025.

Arrowstreet Capital first reported a position in CDNA in Q3 2020 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Arrowstreet Capital held 372,111 shares of CareDx worth $10.6M as of Q2 2026.
  • CareDx was a new Arrowstreet Capital position in Q2 2026.
  • CareDx made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1059 holding.
  • Arrowstreet Capital first reported a position in CareDx in Q3 2020 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.